-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Omada Health, Raises Price Target to $25

Benzinga·08/03/2026 12:16:48
語音播報
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $20 to $25.